T4 bacteriophage nanoparticles engineered through CRISPR provide a versatile platform for rapid development of flu mucosal vaccines
Mengling Li, Cen Chen, Xialin Wang, Pengju Guo, Helong Feng, Xueqi Zhang, Wanpo Zhang, Changqin Gu, Jingen Zhu, Guoyuan Wen, Yaoyu Feng, Lihua Xiao, Guiqing Peng, Venigalla B. Rao, Tao Pan
Topics & Concepts
CRISPRCapsidVirologyBacteriophageImmune systemAntigenNasal administrationVirusMicrobiologyEffectorBiologyEscherichia coliCell biologyImmunologyGeneGeneticsSARS-CoV-2 and COVID-19 ResearchBacteriophages and microbial interactionsMonoclonal and Polyclonal Antibodies Research